Brivaracetam Oral Solution
Product Images NDC 71921-410

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Brivaracetam Oral Solution (NDC 71921-410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brivaracetam-carton (Brivaracetam Carton)

The label for Brivaracetam Oral Solution 10 mg/mL features a 300 mL prescription liquid medication. It includes the NDC 71921-410-72, instructions for pharmacists to dispense the medication guide, and storage conditions advising 20° to 25°C with permitted excursions. The label identifies manufacturing by Indoco Remedies Ltd. in India and labeling by Florida Pharmaceutical Products, LLC, Boca Raton, FL.*

FDA Label Image

Brivaracetam-container (Brivaracetam Container)

Label for Brivaracetam Oral Solution 10 mg/mL, an oral liquid formulation. The label indicates a 300 mL bottle size and highlights storage instructions and pharmacist dispensing information. It is manufactured for Florida Pharmaceutical Products, LLC, with manufacturing by Indoco Remedies Ltd. The label includes the NDC 71921-410 and barcode.*

FDA Label Image

Brivaracetam-fig-1 (Brivaracetam Figure 1)

Bar chart showing the proportion of patients (%) by reduction in seizure frequency from baseline (%) for placebo and three Brivaracetam dosage groups (50 mg/day, 100 mg/day, 200 mg/day). The horizontal axis categorizes seizure reduction in ranges: Worse, 0 to <25%, 25 to <50%, 50 to <75%, and 75 to 100%. The vertical axis represents the proportion of patients. Each group is represented by different bar patterns and colors as indicated in the legend.*

FDA Label Image

Brivaracetam-fstructure (Brivaracetam Structure)

Chemical structure of brivaracetam, the active ingredient in Brivaracetam oral Solution 10 mg/mL by Florida Pharmaceutical Products, LLC. The diagram shows the molecular arrangement including rings, amino and carbonyl groups characteristic of brivaracetam.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.